Trial intelligence / Profile preview

Interaction of Cytochrome P450 Inhibition With Metamizole Metabolism

NCT04621253Phase 1Completed

Sponsor
University Hospital Basel
Start
Apr 2020
Primary completion
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of Metamizole sodium in pain (3 arms), sponsored by University Hospital Basel. Primary endpoints: Area Under the Plasma Concentration vs Time Curve at 24 hours, Peak Plasma Concentration at 24 hours and 2 more. Started Apr 2020; status: completed.

02

Drugs

Metamizole sodium
03

Conditions

pain

Beyond the preview

Go deeper on NCT04621253.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04621253.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call